
Sunday, June 04, 2006 1:15:12 AM
The Doylestown, Pa., company, known for the Cold-Eeze line of cold remedies, said the masks were tested against the H5N1 avian flu virus and the H3N2 straing of the human flu. The masks with QR-441 prevented up to 99% of the viruses whereas the untreated masks had the ability to prevent up to 90% of the viruses getting through.
The Most Read Stories From TheStreet.com
1. Sirius CEO Is Buying
2. Summer Roller Coaster Just Getting Started
3. A Fool's Gold Play
4. Ciena's Bright Spot
5. The Sweet Clatter of Falling Metal
Sign Up Free
Additionally, Quiqley said the QR-441 compound was found to deactivate the live viruses passing through the filters at a rate of 95.1% to 98.7%. The QR-441 study took place at the U.K.'s University of London.
Shares of Quigley were up $2, or 14%, to $16.10.
http://www.thestreet.com/_yahoo/stocks/biotech/10255369.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite...
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM